Paper32026314
Attenuation of Tumor Necrosis Factor-α Induced Inflammation by Umbilical Cord-Mesenchymal Stem Cell Derived Exosome-Mimetic Nanovesicles in Endothelial Cells.
Ko KW and 7 others. Tissue Eng Regen Med, 2020. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Attenuation of Tumor Necrosis Factor-α Induced Inflammation by Umbilical Cord-Mesenchymal Stem Cell Derived Exosome-Mimetic Nanovesicles in Endothelial Cells. Papers, record 32026314. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32026314
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Attenuation of Tumor Necrosis Factor-α Induced Inflammation by Umbilical Cord-Mesenchymal Stem Cell Derived Exosome-Mimetic Nanovesicles in Endothelial Cells.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomimetics | Major topic |
| Endothelial Cells | Major topic |
| Exosomes | Major topic |
| Inflammation | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Umbilical Cord | Major topic |
| Atherosclerosis | |
| Cell Adhesion | |
| Cytokines | |
| Humans | |
| Reactive Oxygen Species | |
| THP-1 Cells |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2017R1A6A3A04012362 javascript: | National Research Foundation of Korea | International | PubMed | |
| 2017R1A2B3011121 | National Research Foundation of Korea | International | PubMed | |
| 2018M3A9E2024579 | National Research Foundation of Korea | International | PubMed | |
| HI18C0089 | Korea Health Industry Development Institute | International | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31089420 | Stem Cell-Derived Exosomes Prevent Aging-Induced Cardiac Dysfunction through a Novel Exosome/lncRNA MALAT1/NF-κB/TNF-α Signaling Pathway. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31089420 | PubMed |
| 2 | 29085024 | Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative. | Sci Rep | 2017 | https://conductscience.org/library/papers/29085024 | PubMed |
| 3 | 18752467 | MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. | Clin Sci (Lond) | 2008 | https://conductscience.org/library/papers/18752467 | PubMed |
| 4 | 9712064 | The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. | J Immunol | 1998 | https://conductscience.org/library/papers/9712064 | PubMed |
| 5 | 25442884 | Hyaluronan protection of corneal endothelial cells against extracellular histones after phacoemulsification. | J Cataract Refract Surg | 2014 | https://conductscience.org/library/papers/25442884 | PubMed |
| 6 | 7542214 | Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. | FASEB J | 1995 | https://conductscience.org/library/papers/7542214 | PubMed |
| 7 | 9277478 | alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. | Am J Physiol | 1997 | https://conductscience.org/library/papers/9277478 | PubMed |
| 8 | 29410409 | Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo. | Sci Rep | 2018 | https://conductscience.org/library/papers/29410409 | PubMed |
| 9 | 30601470 | Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis. | Biomater Sci | 2019 | https://conductscience.org/library/papers/30601470 | PubMed |
| 10 | 18600364 | The role of inflammatory cytokines in endothelial dysfunction. | Basic Res Cardiol | 2008 | https://conductscience.org/library/papers/18600364 | PubMed |
| 11 | 22138068 | Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. | J Control Release | 2012 | https://conductscience.org/library/papers/22138068 | PubMed |
| 12 | 11877368 | Inflammation and atherosclerosis. | Circulation | 2002 | https://conductscience.org/library/papers/11877368 | PubMed |
| 13 | 29572968 | Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy. | Adv Mater | 2018 | https://conductscience.org/library/papers/29572968 | PubMed |
| 14 | 8386742 | Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. | J Exp Med | 1993 | https://conductscience.org/library/papers/8386742 | PubMed |
| 15 | 31129523 | Persulfated flavonoids accelerated re-endothelialization and improved blood compatibility for vascular medical implants. | Colloids Surf B Biointerfaces | 2019 | https://conductscience.org/library/papers/31129523 | PubMed |
| 16 | 30603566 | Three-Dimensional Spheroid Culture Increases Exosome Secretion from Mesenchymal Stem Cells. | Tissue Eng Regen Med | 2018 | https://conductscience.org/library/papers/30603566 | PubMed |
| 17 | 11726207 | Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. | Biochem Biophys Res Commun | 2001 | https://conductscience.org/library/papers/11726207 | PubMed |
| 18 | 30700139 | Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. | Circulation | 2019 | https://conductscience.org/library/papers/30700139 | PubMed |
| 19 | 11781339 | p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. | J Cell Biol | 2002 | https://conductscience.org/library/papers/11781339 | PubMed |
| 20 | 24004438 | Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. | ACS Nano | 2013 | https://conductscience.org/library/papers/24004438 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42920636 | Application of natural products combined with plant-derived extracellular vesicles in cancer therapy. | Exp Biol Med (Maywood) | 2026 | https://conductscience.org/library/papers/42920636 | PubMed |
| 42277017 | Stem cell-derived extracellular vesicles and artificial nanovesicles: a translational framework for cell-free wound repair. | NPJ Regen Med | 2026 | https://conductscience.org/library/papers/42277017 | PubMed |
| 41342990 | Extracellular Vesicles: a Promising Therapy for Treatment of Central Nervous System Ischemia Reperfusion Injury. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41342990 | PubMed |
| 41078403 | Biological Nanotherapeutics Derived From Human Umbilical Cord Mesenchymal Stem Cells: Mechanisms and Translational Potential in Multisystem Therapies for Regeneration and Oncology. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41078403 | PubMed |
| 41012468 | A Bibliometric Analysis of Strategies for Atherosclerosis Treatment with Organic Nanoparticles. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012468 | PubMed |
| 40781916 | Unveiling the multifaceted roles of extracellular vesicles in cancer: insights from molecular imaging and engineering strategies. | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/40781916 | PubMed |
| 40713733 | Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40713733 | PubMed |
| 40705153 | Characterization of extracellular vesicles derived from cortical bone stem cells compared with mesenchymal stem cells. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/40705153 | PubMed |
| 40453695 | Human induced pluripotent stem cell derived nanovesicles for cardiomyocyte protection and proliferation. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40453695 | PubMed |
| 40322740 | Extracellular vesicles: From large-scale production and engineering to clinical applications. | J Tissue Eng | 2025 | https://conductscience.org/library/papers/40322740 | PubMed |
| 40282242 | Advances in Plant-Derived Extracellular Vesicle Extraction Methods and Pharmacological Effects. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40282242 | PubMed |
| 40125436 | From Plant Based Therapy to Plant-Derived Vesicle-Like Nanoparticles for Cancer Treatment: Past, Present and Future. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40125436 | PubMed |
| 39796081 | Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39796081 | PubMed |
| 39458635 | Biomimetic Nanoparticles for Basic Drug Delivery. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39458635 | PubMed |
| 39085567 | Mesenchymal stromal cells and their secretory products reduce the inflammatory crosstalk between islets and endothelial cells. | Endocrine | 2025 | https://conductscience.org/library/papers/39085567 | PubMed |
| 38938599 | GMP-compliant manufacturing of biologically active cell-derived vesicles produced by extrusion technology. | J Extracell Biol | 2022 | https://conductscience.org/library/papers/38938599 | PubMed |
| 38696618 | Targeted Rapamycin Delivery via Magnetic Nanoparticles to Address Stenosis in a 3D Bioprinted in Vitro Model of Pulmonary Veins. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38696618 | PubMed |
| 38337604 | Trans-Arterial Stem Cell Injection (TASI): The Role of Interventional Radiology in Regenerative Medicine. | J Clin Med | 2024 | https://conductscience.org/library/papers/38337604 | PubMed |
| 37749882 | Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37749882 | PubMed |
| 37669775 | Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics against Chronic Liver Disease. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/37669775 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32026314
GET https://conductscience.org/api/papers/v1/32026314/references?page=2